SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Natera’s Signatera Genome Highlighted at ESMO Symposium

Natera said its oncology portfolio appeared in 25 ESMO abstracts, including nine oral presentations.

NTRA

Related stories